StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
CLIS.TA$26690.00+0.53%
Fair $26690.00+0.0%

CLIS.TA

Clal Insurance Enterprises Holdings Ltd.

Financial Services / Insurance - LifeTel Aviv

$26690.00

+150.00 (+0.53%)

Fairly Valued+0.0%Fair Value $26690.00Fund rank 19/100 · Data gapFallback financials|
SA 64/B
F-Score: 7/9

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 41.0/100

Data gap 19/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 5/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

64/100

B

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified.
Thesis & Journal · CLIS.TALocal privado en este navegador · Clal Insurance Enterprises Holdings Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$21.6B

P/E

9.6x

↓

EV/EBITDA

N/A

•

ROE

21.0%

↑

Gross Margin

N/A

•

Debt/Equity

1.60

↑
52-Week Range$26690
$8550$29900

TradingView lightweight chart

CLIS.TA price, volumen y niveles de valoración

Último $28,330Periodo +434.5%
Fair value: $26,690

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+46.4%

FCF CAGR

—

FCF margin

9.2%

FCF / Net income

0.93x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $22.92B · net income $2.28B · FCF $2.11B

2022-FY → 2025-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

9.9%+8.3% pts

FCF margin

9.2%+47.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$22.92B$22.92B$18.50B$21.45B$7.31B
Net Income$2.28B$2.28B$1.54B$220.0M$121.0M
EPS27.4727.4719.382.791.62
Net Margin9.9%9.9%8.3%1.0%1.7%
Balance Sheet
Debt/Equity1.601.601.712.020.07
Current Ratio3.303.30———
Cash Flow
Free Cash Flow$2.11B$2.11B$1.18B$-4.64B$-2.80B
Returns
ROE21.0%21.0%17.6%3.0%1.5%
Valuation
P/E9.629.62472.552177.063819.14
P/B204.36204.3683.2665.8657.52
Growth & Yield
Revenue Growth23.9%23.9%-13.8%193.6%—
EPS Growth41.7%41.7%594.6%72.2%—
Dividend Yield1.8%1.8%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

341.8%

muy exigente

EPS terminal req.

$2368.29

Spread vs growth

-300.0%

5Y implied EPS CAGR

153.3%

muy exigente

EPS terminal req.

$2865.63

Spread vs growth

-111.6%

10Y implied EPS CAGR

66.9%

muy exigente

EPS terminal req.

$4615.13

Spread vs growth

-25.2%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +221.2%

Total return

+221.2%

Start / end P/E

457.6x → 1031.3x

EPS bridge

19.38 → 27.47

Residual

+52.3%

EPS growth+41.7%
Multiple rerating+125.4%
Dividend+1.8%
Residual / FX / buybacks / cross-term+52.3%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.